These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Prasad AR; Savera AT; Gown AM; Zarbo RJ Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827 [TBL] [Abstract][Full Text] [Related]
5. Thomsen-Friedenreich (T) antigen as marker of myoepithelial and basal cells in the parotid gland, pleomorphic adenomas and adenoid cystic carcinomas. An immunohistological comparison between T and sialosyl-T antigens, alpha-smooth muscle actin and cytokeratin 14. Therkildsen MH; Mandel U; Christensen M; Dabelsteen E APMIS; 1995; 103(7-8):558-67. PubMed ID: 7576573 [TBL] [Abstract][Full Text] [Related]
6. Pleomorphic adenomas, adenoid cystic carcinomas and adenolymphomas of salivary glands analysed by a monoclonal antibody against myoepithelial/basal cells. An immunohistochemical study. Caselitz J; Osborn M; Hamper K; Wustrow J; Rauchfuss A; Weber K Virchows Arch A Pathol Anat Histopathol; 1986; 409(6):805-16. PubMed ID: 2429435 [TBL] [Abstract][Full Text] [Related]
7. Vimentin as a marker of myoepithelial cells in salivary gland tumors. de Araújo VC; de Araújo NS Eur Arch Otorhinolaryngol; 1990; 247(4):252-5. PubMed ID: 2165413 [TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas. Souza Freitas V; Dos Santos JN; de Andrade Santos PP; Nonaka CFW; Pereira Pinto L; de Souza LB Eur Arch Otorhinolaryngol; 2018 Dec; 275(12):3075-3082. PubMed ID: 30361787 [TBL] [Abstract][Full Text] [Related]
9. Myoepithelial cells in salivary gland tumors. An immunohistochemical study. Kahn HJ; Baumal R; Marks A; Dardick I; van Nostrand AW Arch Pathol Lab Med; 1985 Feb; 109(2):190-5. PubMed ID: 2579620 [TBL] [Abstract][Full Text] [Related]
10. Actin versus vimentin in myoepithelial cells of salivary gland tumors. A comparative study. de Araujo VC; Carvalho YR; de Araujo NS Oral Surg Oral Med Oral Pathol; 1994 Apr; 77(4):387-91. PubMed ID: 8015803 [TBL] [Abstract][Full Text] [Related]
11. Immunolocalization of three novel smooth muscle-specific proteins in salivary gland pleomorphic adenoma: assessment of the morphogenetic role of myoepithelium. Savera AT; Gown AM; Zarbo RJ Mod Pathol; 1997 Nov; 10(11):1093-100. PubMed ID: 9388059 [TBL] [Abstract][Full Text] [Related]
12. Cytokeratins, smooth muscle actin and vimentin in human normal salivary gland and pleomorphic adenomas. Immunohistochemical studies with particular reference to myoepithelial and basal cells. Draeger A; Nathrath WB; Lane EB; Sundström BE; Stigbrand TI APMIS; 1991 May; 99(5):405-15. PubMed ID: 1710474 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic criteria for neoplastic myoepithelial cells in pleomorphic adenomas and myoepitheliomas. Immunocytochemical detection of muscle-specific actin, cytokeratin 14, vimentin, and glial fibrillary acidic protein. Takai Y; Dardick I; Mackay A; Burford-Mason A; Mori M Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Mar; 79(3):330-41. PubMed ID: 7542546 [TBL] [Abstract][Full Text] [Related]